Management of Acute Carbon Monoxide Poisoning
All patients with acute symptomatic carbon monoxide poisoning should receive immediate high-flow normobaric oxygen therapy via non-rebreather mask, and hyperbaric oxygen therapy (HBO2) should be strongly considered for all symptomatic cases, ideally administered within 6 hours of exposure to optimize neurocognitive outcomes. 1, 2
Immediate Oxygen Therapy
- Administer 100% normobaric oxygen immediately via high-flow non-rebreather mask or endotracheal tube for intubated patients 1
- Normobaric oxygen reduces CO elimination half-life from 4-5 hours to approximately 85 minutes (range 26-148 minutes) 1
- Continue oxygen therapy until HBO2 can be administered, or until the patient is asymptomatic with normalized carboxyhemoglobin levels 1
Indications for Hyperbaric Oxygen Therapy
HBO2 should be considered for ALL symptomatic patients with acute CO poisoning, not just those with severe presentations 3, 4. The goal is prevention of long-term neurocognitive dysfunction, not just short-term survival 1.
Strong Indications Include:
- Any symptomatic patient (headache, nausea, dizziness, altered mental status, chest pain) 1, 3
- Loss of consciousness at any point 1
- Neurological deficits or cerebellar dysfunction 5
- Cardiac ischemia or arrhythmias 1
- Pregnant patients (fetal distress is a major concern) 1
- Pediatric patients (apply adult criteria) 1
- Concomitant cyanide poisoning or smoke inhalation 3, 4
Critical Timing Consideration:
- HBO2 initiated within 6 hours of exposure produces significantly better 6-month neurocognitive outcomes compared to treatment at 6-24 hours 2
- Treatment between 6-12 hours shows intermediate outcomes, while 12-24 hours shows the poorest results 2
- Even patients appearing clinically stable should not have HBO2 withheld based solely on good clinical appearance 1
HBO2 Treatment Protocol
- Treat at 2.5-3.0 atmospheres absolute (atm abs) for the first session 1, 6
- HBO2 reduces CO elimination half-life to approximately 20 minutes 1
- Administer three HBO2 treatments within a 24-hour period based on the highest quality randomized trial showing 25% cognitive sequelae rate versus 46.1% with normobaric oxygen at 6 weeks 5
- Persistently symptomatic patients may require additional treatments at the discretion of the hyperbaric physician 1
Mechanisms Beyond CO Elimination
HBO2 provides benefits beyond simply accelerating carboxyhemoglobin elimination 3, 4:
- Improves mitochondrial function 3, 4
- Inhibits lipid peroxidation 3, 4
- Impairs leukocyte adhesion to injured microvasculature 3, 4
- Reduces brain inflammation from CO-induced myelin basic protein adduct formation 3, 4
- Favorably modulates inflammatory processes not affected by normobaric oxygen 4
Common Pitfalls to Avoid
- Do not rely solely on carboxyhemoglobin levels to determine HBO2 need—even patients with "mild" poisoning (COHb <20%) can develop residual cognitive sequelae 1
- Do not withhold HBO2 because the patient appears clinically well—only 3% of hospitalized CO-poisoned patients die, but up to 68% may develop neurologic sequelae 1
- Do not delay HBO2 for logistical reasons when feasible—every hour of delay worsens 6-month outcomes 2
- Be aware that patients may develop delayed neurological sequelae (DNS) 2-21 days after exposure, which may also respond to HBO2 treatment 1, 7
Special Populations
- Pregnant women: Apply adult treatment criteria; fetal distress and death are major concerns, and HBO2 has been safely administered 1
- Burn patients: Defer HBO2 decisions to experienced burn surgeons when burns pose greater mortality risk than CO poisoning 1
- Patients with APOE ε4 allele: May not derive benefit from HBO2, but since most individuals lack this allele, treat all patients empirically 1